Condition
Rheumatic Heart Disease in Children
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 2 (2)
Trial Status
Recruiting2
Suspended1
Unknown1
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06720272Not ApplicableRecruitingPrimary
School-based Program for the Prevention of Rheumatic Heart Disease in Endemic Regions
NCT07078357Phase 1Not Yet Recruiting
Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor
NCT05682196Phase 2SuspendedPrimary
Rituximab in Patients With Acute Rheumatic Fever
NCT05504928Not ApplicableRecruiting
Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease
NCT03346525Phase 2UnknownPrimary
Determining the Impact of Penicillin in Latent RHD: The GOAL Trial
Showing all 5 trials